Rompe Pecho Nt Liquid
NDC Package 58593-003-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Rompe Pecho Nt (acetaminophen, dextromethorphan hbr, doxylamine succinate) liquids is uses • temporarily relieves these common cold/flu symptoms: • minor aches and pains• headache• sore throat• runny nose and sneezing • cough • relieves cough to help you get to sleep • temporarily reduces fever. This formulation utilizes a liquid delivery system. Marketed by Efficient Laboratories Inc, this product is identified by NDC 58593-003 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
58593-003-06
Package Description
180 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
58593000306
RxNorm Crosswalk
  • RxCUI: 1042675 - acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG in 15 mL Oral Solution
  • RxCUI: 1042675 - acetaminophen 21.7 MG/ML / dextromethorphan hydrobromide 0.667 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution
  • RxCUI: 1042675 - acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG per 15 ML Oral Solution
  • RxCUI: 1042675 - acetaminophen 650 MG / dextromethorphan HBr 20 MG / doxylamine succinate 12.5 MG per 30 ML Oral Solution
  • RxCUI: 1042675 - APAP 21.7 MG/ML / Dextromethorphan Hydrobromide 0.667 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution

Clinical Specifications

Proprietary Name
Rompe Pecho Nt NT
Non-Proprietary Name
Acetaminophen, Dextromethorphan Hbr, Doxylamine Succinate
Substance Name
Acetaminophen; Dextromethorphan Hydrobromide; Doxylamine Succinate
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Uses • temporarily relieves these common cold/flu symptoms: • minor aches and pains• headache• sore throat• runny nose and sneezing • cough • relieves cough to help you get to sleep • temporarily reduces fever.

Regulatory & Marketing

Labeler Name
Efficient Laboratories Inc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-01-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58593-003-06 identifies a specific commercial package of 180 ml in 1 bottle of Rompe Pecho Nt NT, a human over the counter drug labeled by Efficient Laboratories Inc. This liquid is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide; doxylamine succinate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Efficient Laboratories Inc on October 01, 2023. The current certification is valid through December 31, 2026.

How is this Efficient Laboratories Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58593000306. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
58593-003-06
11-Digit CMS (5-4-2)
58593-0003-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.